Cytomegalovirus (CMV) Antikörper
Kurzübersicht für Cytomegalovirus (CMV) Antikörper (ABIN3026155)
Target
Alle Cytomegalovirus (CMV) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- CMV Antibody / Cytomegalovirus / CMV-p65 (azide and preservative free)
-
Aufreinigung
- Protein G affinity
-
Isotyp
- IgG1, kappa
-
-
-
-
Applikationshinweise
- The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the CMV antibody to be titered up or down for optimal performance.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the CMV antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Cytomegalovirus (CMV)
-
Andere Bezeichnung
- CMV
-
Substanzklasse
- Virus
-
Hintergrund
- Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.
Target
-